primary Myelodysplastic Syndromes (MDS)

DBCOND0153442Hemic and Lymphatic DiseasesNeoplasms

primary Myelodysplastic Syndromes (MDS) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
de Novo Myelodysplastic Syndrome · De Novo Myelodysplastic Syndromes · Myelodysplastic Syndromes, de Novo
Classified under
Indicated drugs

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
91Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for primary Myelodysplastic Syndromes (MDS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In